NaturalendoTech announced on March 24ththat the safety of EstroG-100 was scientifically reconfirmed.

Naturalendo Tech has reconfirmed the safety andefficacy of EstroG-100 on menopausal symptoms through the study complying withthe OECD guideline.

The r esearchers at Chungnam National University havereported that the results of in-vitro test showed that EstroG-100 does notactivate the estrogen receptors - The activation of the estrogen receptors hasbeen reported to cause breast cancer and endometrial cancer. As a result,EstroG-100 has been proven to be safe in estrogen-related evaluations, and thestudy has been published in ‘Toxicological Research’.